Letters to the editor...Jones BW, Moore DJ, Robinson SM et al. (2002) A systematic review of tegaserod for the treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics, 27, 343-352

Bibliographic Details
Published in:Journal of Clinical Pharmacy & Therapeutics Vol. 28; no. 2; pp. 151 - 154
Main Authors: Bergmann K, Jones BW
Format: commentary letter response Journal Article
Published: Wiley-Blackwell Apr2003
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106858744&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106858744
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02694727
        EV4
      jtl: Journal of Clinical Pharmacy & Therapeutics
      issn: 02694727
      maglogo: Y
    pubinfo:
      dt: Apr2003
      vid: 28
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106858744
        2003105607
        10.1046/j.1365-2710.2003.00473.x
        NLM12713613
        106858744
      ppf: 151
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Letters to the editor...Jones BW, Moore DJ, Robinson SM et al. (2002) A systematic review of tegaserod for the treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics, 27, 343-352
      aug:
        au:
          Bergmann K
          Jones BW
      sug:
        subj:
          Irritable Bowel Syndrome Drug Therapy
          Serotonin Agonists Therapeutic Use
          Serotonin Agonists Adverse Effects
      pubtype: Academic Journal
      doctype:
        commentary
        letter
        response
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N